I de to seneste tiår er injektion af langtidsvirkende gonadotropinfrigørende hormonanaloger (GnRH- analoger) blevet anvendt til at opnå suppression af testosteron.
For the last two decades, injection of long-acting luteinizing hormone-releasing hormone agonists (LH-RHas) has been used to achieve androgen ablation.